Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.32 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HMGCR | P04035 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2223767 | 0.78 | — | — | |
| SCHEMBL9188246 | 0.75 | TET2 (0.45) | NPC1RAB9A | |
| SCHEMBL2933753 | 0.75 | HTR1A (0.32) | NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL3461929 | 0.72 | — | — | |
| SCHEMBL7303460 | 0.72 | TSHR (0.43) | MAPK1SMN1; SMN2ALDH1A1TSHR | |
| SCHEMBL20173442 | 0.70 | — | — | |
| SCHEMBL3085260 | 0.70 | — | — | |
| SCHEMBL11438338 | 0.70 | PTGES (0.35) | RAB9ASMN1; SMN2ALDH1A1 | |
| SCHEMBL10952646 | 0.70 | — | — | |
| SCHEMBL3462568 | 0.70 | METAP2 (0.39) | EGLN1SMN1; SMN2ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2550251-B1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACID OR SALT THEREOF | SUMITOMO CHEMICAL CO (JP) | 2015-04-29 | — | — | EP | disclosed |
| US-8779190-B2 | Process for producing sulfur-containing amino acid or salt thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-07-15 | — | — | US | disclosed |
| EP-2609077-A1 | PROCESS FOR PREPARING SULFUR-CONTAINING 2-KETOCARBOXYLATE COMPOUND | Sumitomo Chemical Company Limited (JP) | 2013-07-03 | — | — | EP | disclosed |
| EP-2609076-A1 | PROCESS FOR PREPARING SULFUR-CONTAINING 2-KETOCARBOXYLATE COMPOUND | Sumitomo Chemical Co., Ltd (JP) | 2013-07-03 | — | — | EP | disclosed |
| US-20130137896-A1 | PROCESS FOR PREPARING SULFUR-CONTAINING 2-KETOCARBOXYLATE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-05-30 | — | — | US | disclosed |
| US-20130137897-A1 | PROCESS FOR PREPARING SULFUR-CONTAINING 2-KETOCARBOXYLATE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-05-30 | — | — | US | disclosed |
| EP-2550251-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACID OR SALT THEREOF | Sumitomo Chemical Company, Limited (JP) | 2013-01-30 | — | — | EP | disclosed |
| US-20130012737-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACID OR SALT THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-01-10 | — | — | US | disclosed |
| WO-2012081712-A1 | PROCESS FOR THE PREPARATION OF HYDROXYCARBOXYLIC ACID COMPOUND OR SALT THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-06-21 | — | — | WO | disclosed |
| WO-2012026620-A1 | PROCESS FOR PREPARING SULFUR-CONTAINING 2-KETOCARBOXYLATE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-03-01 | — | — | WO | disclosed |
| WO-2012026619-A1 | PROCESS FOR PREPARING SULFUR-CONTAINING 2-KETOCARBOXYLATE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-03-01 | — | — | WO | disclosed |
| WO-2011118849-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACID OR SALT THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130137896-A1 | PROCESS FOR PREPARING SULFUR-CONTAINING 2-KETOCARBOXYLATE COMPOUND | HPD, STS, HACL2 | OR51E2 1491/4885NPC1 4780/4885RAB9A 4532/4885 |
| US-20130137897-A1 | PROCESS FOR PREPARING SULFUR-CONTAINING 2-KETOCARBOXYLATE COMPOUND | HPD, STS, HAO2 | OR51E2 815/4885NPC1 4710/4885RAB9A 4286/4885 |
| US-20130012737-A1 | PROCESS FOR PRODUCING SULFUR-CONTAINING AMINO ACID OR SALT THEREOF | CBS, ASS1, TST | OR51E2 3742/4885NPC1 3684/4885RAB9A 3947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.